Lower HCRU and costs may be reflective of improved patient care.
A CRISPR mouth-swab test could transform TB screening with rapid, low-cost detection in low-resource and asymptomatic cases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback